189 related articles for article (PubMed ID: 37855955)
21. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
22. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
[TBL] [Abstract][Full Text] [Related]
23. Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.
Shams S; Martola J; Charidimou A; Larvie M; Granberg T; Shams M; Kristoffersen-Wiberg M; Wahlund LO
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939709
[TBL] [Abstract][Full Text] [Related]
24. The correlation between enlarged perivascular spaces and cognitive impairment in Parkinson's disease and vascular parkinsonism.
Tu Y; Zhuo W; Peng J; Huang R; Li B; Liu Y; Zhang C; Zeng X; Huang L
BMC Neurol; 2022 Jul; 22(1):282. PubMed ID: 35906550
[TBL] [Abstract][Full Text] [Related]
25. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
[TBL] [Abstract][Full Text] [Related]
26. Methanol Poisoning as an Acute Toxicological Basal Ganglia Lesion Model: Evidence from Brain Volumetry and Cognition.
Mana J; Vaneckova M; Klempíř J; Lišková I; Brožová H; Poláková K; Seidl Z; Miovský M; Pelclová D; Bukačová K; Maréchal B; Kober T; Zakharov S; Růžička E; Bezdicek O
Alcohol Clin Exp Res; 2019 Jul; 43(7):1486-1497. PubMed ID: 31074872
[TBL] [Abstract][Full Text] [Related]
27. Associations of Vascular Risk Factors and
Laveskog A; Wang R; Vetrano DL; Bronge L; Wahlund LO; Qiu C
J Am Heart Assoc; 2020 Aug; 9(16):e015229. PubMed ID: 32805190
[TBL] [Abstract][Full Text] [Related]
28. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
29. Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson's disease.
Pang H; Wang J; Yu Z; Yu H; Li X; Bu S; Zhao M; Jiang Y; Liu Y; Fan G
J Neurol; 2024 Jun; ():. PubMed ID: 38913186
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance spectroscopy shows associations between neurometabolite levels and perivascular space volume in Parkinson's disease: a pilot and feasibility study.
Donahue EK; Bui V; Foreman RP; Duran JJ; Venkadesh S; Choupan J; Van Horn JD; Alger JR; Jakowec MW; Petzinger GM; O'Neill J
Neuroreport; 2022 May; 33(7):291-296. PubMed ID: 35594442
[TBL] [Abstract][Full Text] [Related]
31. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
[TBL] [Abstract][Full Text] [Related]
32. Associations Between Vascular Risk Factors and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.
Rundek T; Del Brutto VJ; Goryawala M; Dong C; Agudelo C; Saporta AS; Merritt S; Camargo C; Ariko T; Loewenstein DA; Duara R; Haq I
J Alzheimers Dis; 2022; 89(2):437-448. PubMed ID: 35871327
[TBL] [Abstract][Full Text] [Related]
33. Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability.
Potter GM; Chappell FM; Morris Z; Wardlaw JM
Cerebrovasc Dis; 2015; 39(3-4):224-31. PubMed ID: 25823458
[TBL] [Abstract][Full Text] [Related]
34. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
35. MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson's disease.
Fang Y; Gu LY; Tian J; Dai SB; Chen Y; Zheng R; Si XL; Jin CY; Song Z; Yan YP; Yin XZ; Pu JL; Zhang BR
Aging (Albany NY); 2020 Nov; 12(24):25805-25818. PubMed ID: 33234732
[TBL] [Abstract][Full Text] [Related]
36. Enlarged perivascular spaces in brain MRI: Automated quantification in four regions.
Dubost F; Yilmaz P; Adams H; Bortsova G; Ikram MA; Niessen W; Vernooij M; de Bruijne M
Neuroimage; 2019 Jan; 185():534-544. PubMed ID: 30326293
[TBL] [Abstract][Full Text] [Related]
37. Differences in Signal Intensity and Enhancement on MR Images of the Perivascular Spaces in the Basal Ganglia versus Those in White Matter.
Naganawa S; Nakane T; Kawai H; Taoka T
Magn Reson Med Sci; 2018 Oct; 17(4):301-307. PubMed ID: 29343658
[TBL] [Abstract][Full Text] [Related]
38. Hippocampal, basal ganglia and olfactory connectivity contribute to cognitive impairments in Parkinson's disease.
Wylie KP; Kluger BM; Medina LD; Holden SK; Kronberg E; Tregellas JR; Buard I
Eur J Neurosci; 2023 Feb; 57(3):511-526. PubMed ID: 36516060
[TBL] [Abstract][Full Text] [Related]
39. MRI-visible perivascular space volumes, sleep duration and daytime dysfunction in adults with cerebrovascular disease.
Ramirez J; Holmes MF; Berezuk C; Kwan D; Tan B; Beaton D; Scott CJM; Ozzoude M; Gao F; Yu D; Swardfager W; Lawrence-Dewar J; Dowlatshahi D; Saposnik G; Boulos MI; Murray BJ; Symons S; Bartha R; Black SE; Swartz RH; ; Lim A
Sleep Med; 2021 Jul; 83():83-88. PubMed ID: 33991894
[TBL] [Abstract][Full Text] [Related]
40. Association of Dilated Perivascular Spaces and Disease Severity in Patients With Huntington Disease.
Chan ST; Mercaldo ND; Ravina B; Hersch SM; Rosas HD
Neurology; 2021 Feb; 96(6):e890-e894. PubMed ID: 33106388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
